Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway.

BY KATIE THOMAS via NYTimes Health | Disclosure

Death Rates Have Dropped for Seriously Ill Covid Patients

BY RONI CARYN RABIN via NYTimes Health | Disclosure

Why You Shouldn’t Worry About Studies Showing Waning Coronavirus Antibodies

BY APOORVA MANDAVILLI via NYTimes Health | Disclosure

Pfizer C.E.O. All but Rules Out Vaccine Before Election Day

BY KATIE THOMAS via NYTimes Health | Disclosure

Colon Cancer Screening Should Start Earlier, at Age 45, U.S. Panel Says

BY RONI CARYN RABIN via NYTimes Health | Disclosure

This Addiction Treatment Works. Why Is It So Underused?

BY ABBY GOODNOUGH via NYTimes Health | Disclosure

A Chance to Expand Medicaid Rallies Democrats in Crucial North Carolina

BY ABBY GOODNOUGH via NYTimes Health | Disclosure